|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product | |||||
| Separative Work Units | |||||
| Uranium | |||||
| Total product | |||||
| Total revenue | |||||
| Cost of sales | |||||
| Product | |||||
| Service | |||||
| Total cost of sales | |||||
| Gross profit (loss) | |||||
| Advanced technology license and decommissioning costs | |||||
| Selling, general and administrative | |||||
| Amortization of intangible assets | |||||
| Special charges for workforce reductions and advisory costs | |||||
| Operating income (loss) | |||||
| Nonoperating components of net periodic benefit expense (income) | |||||
| Interest expense | |||||
| Interest Expense, Nonoperating | |||||
| Investment income | |||||
| Other Nonoperating Income | |||||
| Income (loss) before income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Net income (loss) | |||||
| Accumulated Deficit | |||||
| Total net income (loss) | |||||
| Distributed earnings allocable to warrant modification | |||||
| Accumulated Deficit | |||||
| Total distributed earnings allocable to warrant modification | |||||
| Preferred stock dividends, undeclared and cumulative | |||||
| Distributed earnings allocable to retired preferred shares | |||||
| Net income (loss) allocable to common stockholders | |||||
| Net income (loss) per common share - basic | |||||
| Net income (loss) per common share - diluted | |||||
| Weighted-average number of shares outstanding: | |||||
| Average number of shares outstanding, basic | |||||
| Average number of shares outstanding, diluted | |||||
| Labor and Related Expense | |||||
| Gain (Loss) on Extinguishment of Debt | |||||
Loading...